Viral Hepatitis Updates: Hepatitis Awareness Month 2018
Hepatitis Awareness Month has started and we are excited to join diverse organizations across the country as they work to raise awareness of the importance of vaccination for hepatitis A and B, testing for hepatitis B and C, the availability of effective care and treatments that, in the case of hepatitis C, result in a cure for most people. In addition, Hepatitis Testing Day is May 19, a day for people at risk for viral hepatitis to be tested, and for health care providers to educate patients about chronic viral hepatitis and testing. Here are a few of the many events you can join:
Read more »
Viral Hepatitis Updates from the HHS Office of HIV/AIDS and Infectious Disease Policy
In the final days of National Minority Health Month, we want to highlight disparities in the health status of racial and ethnic minority populations in the United States and share opportunities to address the disparities in viral hepatitis. The theme for 2018 is “Partnering for Health Equity,” which highlights partnerships at the federal, state, local, tribal and territorial levels that help reduce disparities in health and health care. This year’s focus on partnerships is a great way to advance one of the goals of the National Viral Hepatitis Action Plan (Action Plan)—reducing hepatitis B and C health disparities— which can be achieved by bringing together a broad group of stakeholders like you.
Read more »
USDA grant programs address opioid misuse in rural communities
The U.S. Department of Agriculture is making grants available for projects building local responses to opioid misuse in rural communities through its Community Facilities Grant Program and Distance Learning and Telemedicine Grant Program. Projects with the primary purpose of providing opioid prevention, treatment or recovery services will receive priority. The application deadline for both programs is June 4, 2018. More information on the grants and how to apply is available on the USDA website.
Read more »
CDC releases guidance on minimizing HIV, HCV impacts of injecting drug use
The U.S. Centers for Disease Control and Prevention has released guidance to assist communities in planning for outbreaks of HIV or hepatitis C virus among people who inject drugs, with an emphasis on developing response plans that avert further transmissions.
Read more »
Public Health Service updates U.S. PrEP Guidelines
The U.S. Public Health Service has updated its clinical practice guidelines for the use of pre-exposure prophylaxis to prevent HIV infection, with new information on the safety and efficacy of PrEP from trials and open-label studies, indications for PrEP use, and a link to further information on the CDC website. Changes are highlighted in the updated guidelines.
Read more »
IDSA: Sign on for strong commitments against TB
The first United Nations General Assembly High Level Meeting on Ending Tuberculosis on September 26, 2018 will present an unprecedented opportunity for UN Member States to make concrete commitments in the meeting’s political declaration towards eliminating the world’s biggest infectious disease killer. Today, on World Health Day, please join us in reconfirming our commitment to eradicating TB.
Read more »
In Memoriam, Scientia Professor David Cooper AO
This announcement is for a third-party program that The Forum for Collaborative Research does not control or provide support for. Please contact the organizers directly with any questions.
As you may have heard by now, the Kirby Institute is mourning the loss of our Director, Scientia Professor David Cooper AO.
David passed away after a short illness at St Vincent’s Hospital, Sydney on Sunday 18 March 2018, aged 68.
Read more »
Viral Hepatitis Updates from the HHS Office of HIV/AIDS and Infectious Disease Policy
The Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services has focused on fostering conversations about the opioid epidemic and how it is affecting the spread of infectious diseases. They're engaging federal, national and local partners to bring examples of the latest evidence and recommendations, strategies being employed, and progress being made at the state and local levels in responding to the opioid epidemic.
Read more »
Press Release: The Liver Forum Announces Publication of Case Definitions Manuscript
Washington DC, Tuesday, February 27, 2018
The Liver Forum is pleased to announce the “Early View” publication of its second manuscript, Case Definitions for Inclusion and Analysis of Endpoints in Clinical Trials for NASH through the Lens of Regulatory Science,published in the peer-reviewed journal Hepatology. The development of this manuscript included input and contributions from key opinion leaders in the field of non-alcoholic steatohepatitis (NASH), and was led by Dr. Mohammad Shadab Siddiqui (Virginia Commonwealth University), Dr. Stephen Harrison (Pinnacle Clinical Research), and Dr. Arun Sanyal (Virginia Commonwealth University). The published article is available at: https://doi.org/10.1002/hep.29607.
Read more »
Viral Hepatitis Updates from the HHS Office of HIV/AIDS and Infectious Disease Policy
We are very pleased to announce the launch of the Partner Planning Guide (Guide) for the National Viral Hepatitis Action Plan 2017-2020 (Action Plan). This strategic planning resource is designed for use by individuals, groups, and organizations that are conducting strategic programs and providing services to prevent, diagnose, and treat hepatitis B (HBV) and/or hepatitis C (HCV).
Read more »
|
|